Notice Title

Consent to the Distribution of New Medicines

Publication Date
26 Mar 2026

Tags

Medicines Act Consent to the distribution of new medicines Health

Notice Number

2026-sl1629
Title
View PDF
File Type and Size
PDF (31 KB)

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: Cold & Flu Day & Night Relief
Component 1:  
Active Ingredients: Chlorphenamine maleate 2mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Film coated tablet
Component 2:  
Active Ingredients: Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Medreich New Zealand Limited
Manufacturer: Medreich Limited, Bengaluru, India
   
Product: Difflam Dry Cough + Antibacterial + Anti-Inflammatory (Blackcurrant Flavour Sugar Free)
Active Ingredients: Benzydamine hydrochloride 1.5mg
Cetylpyridinium chloride 1.33mg
Dextromethorphan hydrobromide monohydrate 10mg
Dosage Form: Lozenge
New Zealand Sponsor: iNova Pharmaceuticals (New Zealand) Limited
Manufacturer: Unique Pharmaceuticals Laboratories, Kadaiya, India
   
Product: Difflam Dry Cough + Antibacterial + Anti-Inflammatory (Pineapple Lime Flavour Sugar Free)
Active Ingredients: Benzydamine hydrochloride 1.5mg
Cetylpyridinium chloride 1.33mg
Dextromethorphan hydrobromide monohydrate 10mg
Dosage Form: Lozenge
New Zealand Sponsor: iNova Pharmaceuticals (New Zealand) Limited
Manufacturer: Unique Pharmaceuticals Laboratories, Kadaiya, India
   
Product: Ferrive (100mg/2mL)
Active Ingredient: Ferric carboxymaltose 178.57mg/mL equivalent to elemental iron 50mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Viatris Limited
Manufacturer: Mylan Laboratories Limited, Hosur, India
   
Product: Ferrive (500mg/10mL)
Active Ingredient: Ferric carboxymaltose 178.57mg/mL equivalent to elemental iron 50mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Viatris Limited
Manufacturer: Mylan Laboratories Limited, Hosur, India
   
Product: Ferrive (1000mg/20mL)
Active Ingredient: Ferric carboxymaltose 178.57mg/mL equivalent to elemental iron 50mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Viatris Limited
Manufacturer: Mylan Laboratories Limited, Hosur, India
   
Product: Haloperidol (Medicianz)
Active Ingredient: Haloperidol 5mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Medsurge Pharma Limited
Manufacturer: Swiss Parenterals Limited, Ahmedabad, India
   
Product: Haloperidol (Medsurge)
Active Ingredient: Haloperidol 5mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Medsurge Pharma Limited
Manufacturer: Swiss Parenterals Limited, Ahmedabad, India
   
Product: Lacosamide-Teva
Active Ingredient: Lacosamide 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Teva Pharma (New Zealand) Limited
Manufacturer: Teva Pharmaceutical Works Private Limited Company, Debrecen, Hungary
   
Product: Lacosamide-Teva
Active Ingredient: Lacosamide 100mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Teva Pharma (New Zealand) Limited
Manufacturer: Teva Pharmaceutical Works Private Limited Company, Debrecen, Hungary
   
Product: Lacosamide-Teva
Active Ingredient: Lacosamide 150mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Teva Pharma (New Zealand) Limited
Manufacturer: Teva Pharmaceutical Works Private Limited Company, Debrecen, Hungary
   
Product: Lacosamide-Teva
Active Ingredient: Lacosamide 200mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Teva Pharma (New Zealand) Limited
Manufacturer: Teva Pharmaceutical Works Private Limited Company, Debrecen, Hungary
   
Product: MedEx Cold & Flu Relief PE Day & Night
Component 1:  
Active Ingredients: Chlorphenamine maleate 2mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Film coated tablet
Component 2:  
Active Ingredients: Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Medreich New Zealand Limited
Manufacturer: Medreich Limited, Bengaluru, India
   
Product: Medreich Cold & Flu Relief PE Day & Night Tablets
Component 1:  
Active Ingredients: Chlorphenamine maleate 2mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Film coated tablet
Component 2:  
Active Ingredients: Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Medreich New Zealand Limited
Manufacturer: Medreich Limited, Bengaluru, India
   
Product: PharmEx Cold & Flu Relief PE Day & Night
Component 1:  
Active Ingredients: Chlorphenamine maleate 2mg
Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Film coated tablet
Component 2:  
Active Ingredients: Paracetamol 500mg
Phenylephrine hydrochloride 5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Medreich New Zealand Limited
Manufacturer: Medreich Limited, Bengaluru, India
   
Product: Plerixafor
Active Ingredient: Plerixafor 20mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: REX Medical Limited
Manufacturer: MSN Laboratories Private Limited, Nandigama, India
   
Product: Tofacitinib Sandoz
Active Ingredient: Tofacitinib citrate 8.075mg equivalent to tofacitinib 5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Sandoz New Zealand Limited
Manufacturers: Granules India Limited, Visakhapatnam, India
Haupt Pharma Amareg GmbH, Regensburg, Germany
   
Product: Vildagliptin/Metformin (Teva)
Active Ingredients: Metformin hydrochloride 850mg
Vildagliptin 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Teva Pharma (New Zealand) Limited
Manufacturer: Bluepharma Industria Farmaceutica S.A., Coimbra, Portugal
   
Product: Vildagliptin/Metformin (Teva)
Active Ingredients: Metformin hydrochloride 1000mg
Vildagliptin 50mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Teva Pharma (New Zealand) Limited
Manufacturer: Bluepharma Industria Farmaceutica S.A., Coimbra, Portugal


Dated this 23rd day of March 2026.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).